News Releases & Statements
News Releases & Statements
FDA Approves the First-in-Class Bispecific Antibody for Treatment of Follicular Lymphoma
Posted On: December 23, 2022 Read More
The Leukemia & Lymphoma Society Honors Six Outstanding Blood Cancer Scientists with 2022 Achievement Awards
Posted On: December 23, 2022 Read More
FDA Approves New Targeted Treatment Option for Certain Forms of Acute Myeloid Leukemia in Adults
Posted On: December 2, 2022 Read More
The Leukemia & Lymphoma Society Earns a Four-Star Rating From Charity Navigator
Posted On: November 16, 2022 Read More
LLS Applauds FDA Approval of New Treatment Option for Pediatric Patients with Hodgkin Lymphoma
Posted On: November 11, 2022 Read More
Crucial LLS Support Drives Approval of New Precision Medicine for Rare Group of Blood Diseases
Posted On: November 4, 2022 Read More
Shred For Red: An Unstoppable Community Hits the Slopes to End Blood Cancer
Posted On: October 31, 2022 Read MoreMedia Requests
Please send all media-related inquiries and interview requests to mediarelations@lls.org. An LLS representative will respond as soon as possible.